Inner Cosmos
Scotts Valley, US · Delaware corporation · 6 known investors
Inner Cosmos develops a minimally invasive brain-computer interface, described as a "digital pill," aimed at treating depression. The company has run an FDA-approved clinical trial for depression and publishes research on its neurotechnology.
Founders & leadership
MG
Meron GribetzFounder
Investors · 6
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 round · 2024
▶$1.9MraisedNov 2024 · 30 investors · Other TechnologyRule 506(b)
▶$1.9MraisedNov 2024 · 30 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Meron GribetzExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $1.9M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Inner Cosmos do?
- Inner Cosmos develops a minimally invasive brain-computer interface, described as a "digital pill," aimed at treating depression. The company has run an FDA-approved clinical trial for depression and publishes research on its neurotechnology.
- Who founded Inner Cosmos?
- Inner Cosmos was founded by Meron Gribetz.
- Who are Inner Cosmos's investors?
- Inner Cosmos's investors include AIR Capital, Brainstorm Ventures, Krillion Ventures, Lool Ventures, Loup Ventures, Starlight Ventures.
- How much funding has Inner Cosmos raised?
- Inner Cosmos has disclosed $1.9M raised across 1 round.
- Where is Inner Cosmos headquartered?
- Inner Cosmos is headquartered in Scotts Valley, US.